Kéri G - Search Results

1

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Brägelmann J, Dammert MA, Dietlein F, Heuckmann JM, Choidas A, Böhm S, Richters A, Basu D, Tischler V, Lorenz C, Habenberger P, Fang Z, Ortiz-Cuaran S, Leenders F, Eickhoff J, Koch U, Getlik M, Termathe M, Sallouh M, Greff Z, Varga Z, Balke-Want H, French CA, Peifer M, Reinhardt HC, Örfi L, Kéri G, Ansén S, Heukamp LC, Büttner R, Rauh D, Klebl BM, Thomas RK, Sos ML. Brägelmann J, et al. Among authors: keri g. Cell Rep. 2017 Sep 19;20(12):2833-2845. doi: 10.1016/j.celrep.2017.08.082. Cell Rep. 2017. PMID: 28930680 Free PMC article.

2

Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.

Németh G, Greff Z, Sipos A, Varga Z, Székely R, Sebestyén M, Jászay Z, Béni S, Nemes Z, Pirat JL, Volle JN, Virieux D, Gyuris Á, Kelemenics K, Ay E, Minarovits J, Szathmary S, Kéri G, Orfi L. Németh G, et al. Among authors: keri g. J Med Chem. 2014 May 22;57(10):3939-65. doi: 10.1021/jm401742r. Epub 2014 May 2. J Med Chem. 2014. PMID: 24742150

3

Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell lines.

Mavromatidis V, Varga Z, Waczek F, Őrfi Z, Őrfi L, Kéri G, Mosialos G. Mavromatidis V, et al. Among authors: keri g. PLoS One. 2014 Apr 23;9(4):e95688. doi: 10.1371/journal.pone.0095688. eCollection 2014. PLoS One. 2014. PMID: 24759913 Free PMC article.

4

Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion.

Rybniker J, Chen JM, Sala C, Hartkoorn RC, Vocat A, Benjak A, Boy-Röttger S, Zhang M, Székely R, Greff Z, Orfi L, Szabadkai I, Pató J, Kéri G, Cole ST. Rybniker J, et al. Among authors: keri g. Cell Host Microbe. 2014 Oct 8;16(4):538-48. doi: 10.1016/j.chom.2014.09.008. Cell Host Microbe. 2014. PMID: 25299337 Free article.

5

Binding specificity of the L-arginine transport systems in mouse macrophages and human cells overexpressing the cationic amino acid transporter hCAT-1.

Eros D, Orfi L, Csuka I, Kéri G, Hrabák A. Eros D, et al. Among authors: keri g. Amino Acids. 2009 Mar;36(3):483-92. doi: 10.1007/s00726-008-0106-x. Epub 2008 May 27. Amino Acids. 2009. PMID: 18504524

6

Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors.

Herczenik E, Varga Z, Eros D, Makó V, Oroszlán M, Rugonfalvi-Kiss S, Romics L, Füst G, Kéri G, Orfi L, Cervenak L. Herczenik E, et al. Among authors: keri g. J Recept Signal Transduct Res. 2009;29(2):75-83. doi: 10.1080/10799890902857976. J Recept Signal Transduct Res. 2009. PMID: 19519173

7

Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.

Torka R, Pénzes K, Gusenbauer S, Baumann C, Szabadkai I, Őrfi L, Kéri G, Ullrich A. Torka R, et al. Among authors: keri g. Neoplasia. 2014 Apr;16(4):301-18. doi: 10.1016/j.neo.2014.03.009. Neoplasia. 2014. PMID: 24862757 Free PMC article.

8

Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases.

Booij TH, Klop MJ, Yan K, Szántai-Kis C, Szokol B, Orfi L, van de Water B, Keri G, Price LS. Booij TH, et al. Among authors: keri g. J Biomol Screen. 2016 Oct;21(9):912-22. doi: 10.1177/1087057116657269. Epub 2016 Jul 7. J Biomol Screen. 2016. PMID: 27412535 Free PMC article.

9

A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.

Székely R, Wáczek F, Szabadkai I, Németh G, Hegymegi-Barakonyi B, Eros D, Szokol B, Pató J, Hafenbradl D, Satchell J, Saint-Joanis B, Cole ST, Orfi L, Klebl BM, Kéri G. Székely R, et al. Among authors: keri g. Immunol Lett. 2008 Mar 15;116(2):225-31. doi: 10.1016/j.imlet.2007.12.005. Epub 2008 Jan 8. Immunol Lett. 2008. PMID: 18258308

10

[Application of Kohonen Self-Organizing Feature Maps in QSAR of human ADMET and kinase data sets].

Hegymegi-Barakonyi B, Orfi L, Kéri G, Kövesdi I. Hegymegi-Barakonyi B, et al. Among authors: keri g. Acta Pharm Hung. 2013;83(4):143-8. Acta Pharm Hung. 2013. PMID: 24575660 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page